<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Kalko, S.G.</author>
      <author>Paco, S.</author>
      <author>Jou, C.</author>
      <author>Rodríguez, M.A.</author>
      <author>Meznaric, M.</author>
      <author>Rogac, M.</author>
      <author>Jekovec-Vrhovsek, M.</author>
      <author>Sciacco, M.</author>
      <author>Moggio, M.</author>
      <author>Fagiolari, G.</author>
      <author>De Paepe, B.</author>
      <author>De Meirleir, L.</author>
      <author>Ferrer, I.</author>
      <author>Roig-Quilis, M.</author>
      <author>Munell, F.</author>
      <author>Montoya, J.</author>
      <author>López-Gallardo, E.</author>
      <author>Ruiz-Pesini, E.</author>
      <author>Artuch, R.</author>
      <author>Montero, R.</author>
      <author>Torner, F.</author>
      <author>Nascimento, A.</author>
      <author>Ortez, C.</author>
      <author>Colomer, J.</author>
      <author>Jimenez-Mallebrera, C.</author>
    </authors>
  </contributors>
  <titles>
    <title>Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies</title>
    <secondary-title>BMC genomics</secondary-title>
  </titles>
  <doi>10.1186/1471-2164-15-91</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2014</year>
    <pub-dates>
      <date>2014</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>